Asian Pacific Journal of Cancer Prevention

  • 제15권1호
  • /
  • Pages.239-244
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Overexpression of NDRG2 Can Inhibit Neuroblastoma Cell Proliferation through Negative Regulation by CYR61

  • Zhang, Zhi-Guo (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) ;
  • Li, Gang (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) ;
  • Feng, Da-Yun (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) ;
  • Zhang, Jian (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University) ;
  • Zhang, Jing (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University) ;
  • Qin, Huai-Zhou (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) ;
  • Ma, Lian-Ting (Postdoctoral Research Station of Neurosurgery, Wuhan General Hospital of Guangzhou Command, PLA) ;
  • Gao, Guo-Dong (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) ;
  • Wu, Lin (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University)
  • 발행 : 2014.01.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Several recent studies have showed that the n-myc downstream regulated gene 2 (NDRG2) is a new tumor suppressor gene, and that it plays an important role in tumor suppression in several cancers or cancer cell lines. However, few studies focused on its function in neuroblastoma cells. In the present investigation, we demonstrated that NDRG2 overexpression inhibited their proliferation. Using a cDNA microarray, we found that overexpression of NDRG2 inhibited the expression of cysteine-rich protein 61 (CYR61), a proliferation related gene. From our research, CYR61 may partially hinder NDRG2-mediated inhibition of cell proliferation. Overexpression of NDRG2 resulted in accumulation of cells in the G1 phase, which was accompanied by upregulation of p21 and p27 and downregulation of CDK4 and cyclin D1. Taken together, these data indicate that NDRG2 inhibits the proliferation of neuroblastoma cells partially through suppression of CYR61. Our findings offer novel insights into the physiological roles of NDRG2 in neuroblastoma cell proliferation, and NDRG2 may prove to be effective candidate for the treatment of children with neuroblastoma.

키워드

참고문헌

  1. Chien W, Kumagai T, Miller CW, et al (2004). Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem, 279, 53087-96. https://doi.org/10.1074/jbc.M410254200
  2. Choi SC, Yoon SR, Park YP, et al (2007). Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med, 39, 705-14. https://doi.org/10.1038/emm.2007.77
  3. Deng Y, Yao L, Chau L, et al (2003). N-Myc downstreamregulated gene 2 (NDRG2). inhibits glioblastoma cell proliferation. Int J Cancer, 106, 342-7. https://doi.org/10.1002/ijc.11228
  4. Foletta VC, Prior MJ, Stupka N, et al (2009). NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol, 587, 1619-34. https://doi.org/10.1113/jphysiol.2008.167882
  5. Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012). The matrix protein CCN1/CYR61 is required for alpha(V). beta(5). -mediated cancer cell migration. Cell Biochem Funct, 30, 687-95 https://doi.org/10.1002/cbf.2853
  6. Kang K, Jung H, Nam S, Lim JS (2011). NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells. Immune Netw, 11, 348-57. https://doi.org/10.4110/in.2011.11.6.348
  7. Kim A, Kim MJ, Yang Y, et al (2009). Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis, 30, 927-36. https://doi.org/10.1093/carcin/bgp072
  8. Kim JT, Kim JW, Kang YH, et al (2012). NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/beta-catenin signaling. FEBS Lett, 586, 3962-8. https://doi.org/10.1016/j.febslet.2012.09.045
  9. Kim YJ, Yoon SY, Kim JT, et al (2009). NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma. Carcinogenesis, 30, 598-605. https://doi.org/10.1093/carcin/bgp047
  10. Kim YJ, Yoon SY, Kim JT, et al (2009). NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer, 124, 7-15. https://doi.org/10.1002/ijc.23945
  11. Lee DC, Kang YK, Kim WH, et al (2008). Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res, 68, 4210-20. https://doi.org/10.1158/0008-5472.CAN-07-5040
  12. Lee KB, Byun HJ, Park SH, et al (2012). CYR61 controls p53 and NF-kappaB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett, 315, 86-95. https://doi.org/10.1016/j.canlet.2011.10.016
  13. Li ZQ, Ding W, Sun SJ, et al (2012). Cyr61/CCN1 is regulated by Wnt/beta-catenin signaling and plays an important role in the progression of hepatocellular carcinoma. PLoS One, 7, e35754. https://doi.org/10.1371/journal.pone.0035754
  14. Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C (2011). Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2). in human cancers with focus on breast cancer. BMC Cancer, 11, 14-21. https://doi.org/10.1186/1471-2407-11-14
  15. Lorentzen A, Vogel LK, Lewinsky RH, et al (2007). Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer, 7, 192-9. https://doi.org/10.1186/1471-2407-7-192
  16. Lusis EA, Watson MA, Chicoine MR, et al (2005). Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res, 65, 7121-6. https://doi.org/10.1158/0008-5472.CAN-05-0043
  17. Ma J, Jin H, Wang H, et al (2008). Expression of NDRG2 in clear cell renal cell carcinoma. Biol Pharm Bull, 31, 1316-20. https://doi.org/10.1248/bpb.31.1316
  18. Matthay KK (1995). Neuroblastoma: a clinical challenge and biologic puzzle. CA Cancer J Clin, 45, 179-92. https://doi.org/10.3322/canjclin.45.3.179
  19. Sabile AA, Arlt MJ, Muff R, et al (2012). Cyr61 expression in Osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. J Bone Miner Res, 27, 58-67 https://doi.org/10.1002/jbmr.535
  20. Salic A, Mitchison TJ (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA, 105, 2415-20. https://doi.org/10.1073/pnas.0712168105
  21. Shi H, Jin H, Chu D, et al (2009). Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull, 32, 968-75. https://doi.org/10.1248/bpb.32.968
  22. Shi H, Li N, Li S, et al (2010). Expression of NDRG2 in esophageal squamous cell carcinoma. Cancer Sci, 101, 1292-9. https://doi.org/10.1111/j.1349-7006.2010.01529.x
  23. Tong X, O'Kelly J, Xie D, et al (2004). Cyr61 suppresses the growth of non-small-cell lung cancer cells via the betacatenin-c-myc-p53 pathway. Oncogene, 23, 4847-55. https://doi.org/10.1038/sj.onc.1207628
  24. Tong X, Xie D, O'Kelly J, et al (2001). Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem, 276, 47709-14. https://doi.org/10.1074/jbc.M107878200
  25. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R (2002). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 21, 8178-85. https://doi.org/10.1038/sj.onc.1205682
  26. Tschan MP, Shan D, Laedrach J, et al (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leuk Res, 34, 393-8 https://doi.org/10.1016/j.leukres.2009.08.037
  27. Xie D, Yin D, Tong X, et al (2004). Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res, 64, 1987-96. https://doi.org/10.1158/0008-5472.CAN-03-0666
  28. Xie D, Yin D, Wang HJ, et al (2004). Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res, 10, 2072-81. https://doi.org/10.1158/1078-0432.CCR-0659-03
  29. Xu C, Zheng J, Zhang H, et al (2012). MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo. Asian Pac J Cancer Prev, 13, 3233-8 https://doi.org/10.7314/APJCP.2012.13.7.3233
  30. Yang J, Li Y, Wu L, et al (2010). NDRG2 in rat liver regeneration: role in proliferation and apoptosis. Wound Repair Regen, 18, 524-31. https://doi.org/10.1111/j.1524-475X.2010.00614.x
  31. Yang J, Zheng J, Wu L, et al (2011). NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One, 6, e27710. https://doi.org/10.1371/journal.pone.0027710
  32. Yao L, Zhang J, Liu X (2008). NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin, 40, 625-35. https://doi.org/10.1111/j.1745-7270.2008.00434.x
  33. Yu Y, Gao Y, Wang H, et al (2008). The matrix protein CCN1 (CYR61). promotes proliferation, migration and tube formation of endothelial progenitor cells. Exp Cell Res, 314, 3198-208. https://doi.org/10.1016/j.yexcr.2008.08.001
  34. Zhao H, Zhang J, Lu J, et al (2008). Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer. BMC Cancer, 8, 303-11. https://doi.org/10.1186/1471-2407-8-303

피인용 문헌

  1. Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers vol.21, pp.6, 2016, https://doi.org/10.1007/s10495-016-1244-3